Genetic Counseling Service

Closed Solicitation Posted

Solicitation number
NIHRFQ123456
Agency
Responses due
Set-aside
Competitive 8(a)

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Solicitation notice is for a Genetic Counseling Service contract to support the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE) research program, which is managed by the National Eye Institute (NEI), part of the National Institutes of Health (NIH). The contractor will be required to provide licensed genetic counseling services, including pre- and post-test counseling, for participants in the eyeGENE research study. Key requirements include timely availability of counseling services nationwide, a hosted patient portal, a coordinating center dashboard, implementation services, and professional services. The evaluation criteria include the vendor's ability to meet requirements, past government experience, delivery timeline, price, and counselor expertise in ophthalmology/rare diseases. The Solicitation number is NIHRFQ123456, and the due date for proposals is May 31, 2024.

The contract is set aside as a competitive 8(a) opportunity. No potential incumbents or current contractors are named. The award value or budget range is not specified. The place of performance is Bethesda, MD 20892, USA.

Notice text

The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®) is a research venture created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH). eyeGENE® aims to advance studies of eye diseases and their genetic causes by giving researchers access to DNA samples, clinical information, and patients that may meet their criteria to participate in research studies and clinical trials.

The eyeGENE® research program will require a genetic counseling service for the newest protocol, per NIH institutional guidance. The eyeGENE® program is offering whole exome sequencing (WES) and whole genome sequencing (WGS) to participants in its recruitment protocol (NIH IRB #: 001647), National Ophthalmic Genotyping and Phenotyping Network, Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases. Genetic testing will be completed by a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory and the results received by the eyeGENE® study team. This clinical testing may return primary results and/or results with secondary findings unrelated to a participant’s eye condition.

Files

File Type Posted
STATEMENT-OF-WORK-GENETIC-COUNSELING (1).pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity